Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence, Reproducibility, and Feasibility of Longitudinal Assessment of Neurocognitive Dysfunction in Adults With Chronic and Persistent Immune Thrombocytopenia (COGFIT)

NCT06817395 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT06817395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06817395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence, Reproducibility, and Feasibility of Longitudinal Assessment of Neurocognitive Dysfunction in Adults With Chronic and Persistent Immune Thrombocytopenia (COGFIT)
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Recruiting
Start date
September 15, 2024
Completion date
September 15, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune thrombocytopenia